- Home
- LEGN vs HSIC Comparison
LEGN vs HSIC Comparison
Compare LEGN & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- HSIC
- Stock Information
- Founded
- LEGN 2014
- HSIC 1932
- Country
- LEGN United States
- HSIC United States
- Employees
- LEGN N/A
- HSIC N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- HSIC Medical Specialities
- Sector
- LEGN Health Care
- HSIC Health Care
- Exchange
- LEGN Nasdaq
- HSIC Nasdaq
- Market Cap
- LEGN 7.0B
- HSIC 8.1B
- IPO Year
- LEGN 2020
- HSIC 1995
- Fundamental
- Price
- LEGN $27.78
- HSIC $72.05
- Analyst Decision
- LEGN Strong Buy
- HSIC Buy
- Analyst Count
- LEGN 13
- HSIC 10
- Target Price
- LEGN $75.67
- HSIC $79.30
- AVG Volume (30 Days)
- LEGN 1.5M
- HSIC 1.4M
- Earning Date
- LEGN 05-13-2025
- HSIC 05-05-2025
- Dividend Yield
- LEGN N/A
- HSIC N/A
- EPS Growth
- LEGN N/A
- HSIC 8.11
- EPS
- LEGN N/A
- HSIC 3.21
- Revenue
- LEGN $728,303,000.00
- HSIC $12,669,000,000.00
- Revenue This Year
- LEGN $65.96
- HSIC $4.32
- Revenue Next Year
- LEGN $52.55
- HSIC $3.51
- P/E Ratio
- LEGN N/A
- HSIC $22.29
- Revenue Growth
- LEGN 112.46
- HSIC 1.75
- 52 Week Low
- LEGN $29.27
- HSIC $60.56
- 52 Week High
- LEGN $60.87
- HSIC $82.49
- Technical
- Relative Strength Index (RSI)
- LEGN 29.61
- HSIC 66.12
- Support Level
- LEGN $30.25
- HSIC $69.64
- Resistance Level
- LEGN $33.30
- HSIC $71.33
- Average True Range (ATR)
- LEGN 1.78
- HSIC 1.83
- MACD
- LEGN -0.57
- HSIC 0.81
- Stochastic Oscillator
- LEGN 5.19
- HSIC 99.37
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.